IMIC(SZ:000516) Sou Hu Cai Jing·2026-01-26 11:01Core Viewpoint - International Medical is expected to report a net profit loss of between 295 million yuan and 315 million yuan for the full year of 2025 due to market fluctuations and DRG payment policy reforms impacting revenue [1] Financial Performance - For the first three quarters of 2025, the company's main revenue was 2.995 billion yuan, a year-on-year decrease of 16.94% [1] - The net profit attributable to shareholders was -294 million yuan, down 38.45% year-on-year [1] - The net profit excluding non-recurring items was -312 million yuan, a decline of 41.94% year-on-year [1] - In the third quarter of 2025, the company's single-quarter main revenue was 961 million yuan, a year-on-year decrease of 18.95% [1] - The single-quarter net profit attributable to shareholders was -129 million yuan, a significant drop of 234.24% year-on-year [1] - The single-quarter net profit excluding non-recurring items was -123 million yuan, down 52.03% year-on-year [1] Operational Metrics - The company's debt ratio stands at 68.8% [1] - Investment income reported was 20.7586 million yuan [1] - Financial expenses amounted to 111 million yuan [1] - The gross profit margin is recorded at 6.59% [1]